Show Summary Details
Page of

Percutaneous coronary intervention in non-ST elevation acute coronary syndrome 

Percutaneous coronary intervention in non-ST elevation acute coronary syndrome
Percutaneous coronary intervention in non-ST elevation acute coronary syndrome

Michael Mahmoudi

and Nick Curzen

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 25 October 2020

Ischaemic heart disease (IHD) accounts for 30% of all deaths in men and 25% of all deaths in women in England and Wales. IHD also remains the commonest cause of death in many industrialized countries. The current global impact of IHD is one of marked contrasts. Many countries with previously high rates of IHD, including the United Kingdom, United States, and Finland, are experiencing declines whereas the rates of IHD are rising in many countries such as central and eastern Europe where the rates were previously ‘low’. The annual incidence of non-ST elevation acute coronary syndrome (NSTEACS) has been estimated at approximately three per 1000 populations. Hospital mortality is greater than in those patients presenting with ST-elevation myocardial infarction (STEMI) (7% vs. 5%), although at 6 months, the mortality rates become similar.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.